Mutational studies of human immunodeficiency virus type 1 reverse transcriptase: The involvement of residues 183 and 184 in the fidelity of DNA synthesis

被引:46
作者
Bakhanashvili, M [1 ]
Avidan, O [1 ]
Hizi, A [1 ]
机构
[1] TEL AVIV UNIV,SACKLER SCH MED,DEPT CELL BIOL & HISTOL,IL-69978 TEL AVIV,ISRAEL
关键词
HIV; reverse transcriptase; mutant; fidelity; DNA synthesis;
D O I
10.1016/0014-5793(96)00747-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The high error rates characteristic of human immunodeficiency virus type-1 reverse transcriptase (HIV-1 RT) are a presumptive source of the viral hypermutability that impedes prevention and therapy of acquired immunodeficiency syndrome (AIDS), We have analyzed two mutants of HIV-1 RT by conducting a comparative study of the accuracy of DNA synthesis, Each mutant bears a single amino acid substitution adjacent to the two aspartic acid residues at positions 185 and 186 in the highly conserved DNA polymerase active site, The first mutant, Met 184 --> Leu (M184L), displays a marked reduction in both misinsertion and mispair extension, suggesting a fidelity of DNA synthesis significantly higher than that of the wild-type HIV-1 RT, The second mutant, Tyr 183 --> Phe (Y183F), shows a decrease in mispair extension with no significant change in misincorporation. Thus, the overall pattern of error-proneness of DNA synthesis is: wild-type HIV-1 RT > Y183F > M184L, Taken together, it is possible that residues 183 and 184 contribute to the low fidelity of DNA synthesis characteristic of the reverse transcriptases of HIV-1, HIV-2 and possibly, of other lentiviruses, Our observations may bear on the nature of potential mutations responsible for resistance to the nucleoside analogs used in chemotherapy of AIDS.
引用
收藏
页码:257 / 262
页数:6
相关论文
共 38 条
[1]   FIDELITY OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 [J].
BAKHANASHVILI, M ;
HIZI, A .
FEBS LETTERS, 1992, 306 (2-3) :151-156
[2]   FIDELITY OF THE RNA-DEPENDENT DNA-SYNTHESIS EXHIBITED BY THE REVERSE TRANSCRIPTASES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 AND OF MURINE LEUKEMIA-VIRUS - MISPAIR EXTENSION FREQUENCIES [J].
BAKHANASHVILI, M ;
HIZI, A .
BIOCHEMISTRY, 1992, 31 (39) :9393-9398
[3]   THE FIDELITY OF THE REVERSE TRANSCRIPTASES OF HUMAN IMMUNODEFICIENCY VIRUSES AND MURINE LEUKEMIA-VIRUS, EXHIBITED BY THE MISPAIR EXTENSION FREQUENCIES, IS SEQUENCE DEPENDENT AND ENZYME RELATED [J].
BAKHANASHVILI, M ;
HIZI, A .
FEBS LETTERS, 1993, 319 (1-2) :201-205
[4]   A POSSIBLE ROLE FOR CYSTEINE RESIDUES IN THE FIDELITY OF DNA-SYNTHESIS EXHIBITED BY THE REVERSE TRANSCRIPTASES OF HUMAN IMMUNODEFICIENCY VIRUSES TYPE-1 AND TYPE-2 [J].
BAKHANASHVILI, M ;
HIZI, A .
FEBS LETTERS, 1992, 304 (2-3) :289-293
[5]   FIDELITY OF DNA-SYNTHESIS EXHIBITED IN-VITRO BY THE REVERSE-TRANSCRIPTASE OF THE LENTIVIRUS EQUINE INFECTIOUS-ANEMIA VIRUS [J].
BAKHANASHVILI, M ;
HIZI, A .
BIOCHEMISTRY, 1993, 32 (29) :7559-7567
[6]   HIV-1 REVERSE-TRANSCRIPTASE - STRUCTURE PREDICTIONS FOR THE POLYMERASE DOMAIN [J].
BARBER, AM ;
HIZI, A ;
MAIZEL, JV ;
HUGHES, SH .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (09) :1061-1072
[7]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[8]  
BEBENEK K, 1993, REVERSE TRANSCRIPTAS, P85
[9]   CASSETTE MUTAGENESIS OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
BOYER, PL ;
FERRIS, AL ;
HUGHES, SH .
JOURNAL OF VIROLOGY, 1992, 66 (02) :1031-1039
[10]   SENSITIVITY OF WILD-TYPE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE TO DIDEOXYNUCLEOTIDES DEPENDS ON TEMPLATE LENGTH - THE SENSITIVITY OF DRUG-RESISTANT MUTANTS DOES NOT [J].
BOYER, PL ;
TANTILLO, C ;
JACOBOMOLINA, A ;
NANNI, RG ;
DING, JP ;
ARNOLD, E ;
HUGHES, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4882-4886